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Stellingen behorend bij het proefschrift 
Positron Emission Tomography for 
Quality Assurance in Proton Therapy 
 
1. Using 12N PET imaging, accurate feedback on the dose delivery 
can be obtained in real-time. 
 
2. Good quality PET data can be obtained during beam delivery  
by removing prompt counts using an anti-coincidence filter 
with the delivered proton bunches. 
 
3. A large dual panel PET scanner that images a single spot at the 
beginning of the dose delivery, can measure a 5 mm range shift 
with millimeter accuracy using 12N imaging. 
 
4. Optimization of in vivo dose delivery verification requires 
detailed investigations of a variety of clinical cases; irradiation 
of simple phantoms does not capture the full complexity of the 
problem. 
 
5. An advantage of PET over prompt gamma ray imaging is the 
fact that the basic technology is not developed solely for range 
verification. 
 
6. The need for accurate range verification is increased by 
developments in hadron therapy such as hypofractionation or 
the use of high instantaneous beam intensities. 
 
7. Fast PET measurements of the in-vivo proton range will 
provide comfort in the delivery of more bold treatment plans 
with reduced margins, which will result in clinical benefits. 
 
8. Technological artifacts can mean different things to different 
people and are shaped by relevant social groups. 
(Pinch and Bijker, 1984) 
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